Cibc Private Wealth Group, LLC Novo Cure LTD Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 209 shares of NVCR stock, worth $3,845. This represents 0.0% of its overall portfolio holdings.
Number of Shares
209Holding current value
$3,845% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
279Shares Held
73MCall Options Held
1.43MPut Options Held
832K-
Vanguard Group Inc Valley Forge, PA10MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.08MShares$167 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$163 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$61.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$43.8 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.93B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...